Column Group LP Insider Profile

88 Followers
Column Group LP, Ten Percent Owner at Immune Design, holds 1.00K shares in NGM Biopharmaceuticals (Ticker: NGM), holds 2.82M shares in Nurix Therapeutics (Ticker: NRIX), holds 6.23M shares in Constellation Pharmaceuticals (Ticker: CNST).
tipranks
Column Group LP

Column Group LP
Immune Design (IMDZ)
Ten Percent Owner

Ranked #196 out of 99,335 Corporate Insiders

Profitable Transactions

76%
60 out of 79 Profitable Transactions

Average Return

+24.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$76M
100.00%
A breakdown of Column Group LP's holdings

Insider Roles

Nurix Therapeutics
(NRIX)
Ten Percent Owner
Roles that Column Group LP holds in companies

Most Profitable Insider Trade

Stock:
Constellation Pharmaceuticals
(CNST)
Rating:Informative Buy
Date:Oct 07, 2019 - Oct 07, 2020
Return:+181.90%
The most profitable trade made by Column Group LP

Column Group LP's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
IMDZ
Immune Design
Apr 02, 2019
Uninformative Sell
38.86M
$0.00
CNST
Constellation Pharmaceuticals
Feb 19, 2021
Informative Sell
369.50K
$211.78M
NGM
NGM Biopharmaceuticals
Apr 08, 2024
Uninformative Sell
$1.54K
Nurix Therapeutics
May 07, 2021
Ten Percent Owner
Uninformative Buy
$76.10M
List of latest transactions for each holding click on a transaction to see Column Group LP's performance on stock

Column Group LP insider profile FAQ

What is the percentage of profitable transactions made by Column Group LP?
The percentage of profitable transactions made by Column Group LP is 76%.
    What is the average return per transaction made by Column Group LP?
    The average return per transaction made by Column Group LP is 24.00%.
      What stocks does Column Group LP hold?
      Column Group LP holds: IMDZ, CNST, NGM, NRIX stocks.
        What was Column Group LP’s latest transaction?
        Column Group LP latest transaction was an Uninformative Sell of ―.
          What was Column Group LP's most profitable transaction?
          Column Group LP’s most profitable transaction was an Informative Buy of CNST stock on October 7, 2019. The return on the trade was 181.90%.
            What is Column Group LP's role in Immune Design?
            Column Group LP's role in Immune Design is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.